Learn more about whether Biogen Inc. or Neurocrine Biosciences, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

CenExel, a leading network of clinical research sites, proudly congratulates and announces its role in supporting Vertex Pharmaceuticals’ clinical studies that led to the FDA approval of JOURNAVX™ ...

Separately, Rakovina Therapeutics expects to receive the first synthesized drug candidates from its second AI-driven drug ...

Developers promise a quantum hub will bring good paying jobs to South Chicago and revitalize the neighborhood. But some ...

After 2024, which saw a steady recovery by the life sciences industry, it looks like 2025 is set to be a year of change and ...

Contract research firm IQVIA Holdings beat Wall Street estimates for fourth-quarter profit and revenue on Thursday, helped by the demand for its healthcare data and analytics services.

Sigachi Industries invests US$ 1 million to establish a state-of-the-art R&D centre in Hyderabad: Our Bureau, Bengaluru Thursday, February 6, 2025, 17:30 Hrs [IST] Sigachi Industr ...

"Medidata is at the forefront of a critical shift in the life sciences sector," said Anthony Costello, CEO, Medidata. "By harnessing AI-powered solutions and partnering with visionaries, we aren't ...

The ambitious plans aim to secure medicine supply, accelerate innovation, strengthen clinical research, and reinforce IP ...

Vietnam’s pharmaceutical market is expected to have a year of optimism after experiencing a multicoloured gamut in 2024.

One of the well-known pharmaceutical businesses, Sigachi Industries Limited (NSE: SIGACHI), has announced the inauguration of ...